Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • respiratory

    Tag: respiratory

    You Searched For "respiratory"
    GSK Pharma to optimise product portfolio to drive growth in India

    GSK Pharma to optimise product portfolio to drive growth in India

    Medical Dialogues Bureau24 Jun 2019 9:19 AM IST
    GSK is also looking to launch some new products in the country over the next 15 months as it adopts a more structured approach to engage trade channel...
    Cipla gets no USFDA observations for Indore facility

    Cipla gets no USFDA observations for Indore facility

    Farhat Nasim18 May 2019 9:45 AM IST
    The US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
    AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise

    AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise

    Medical Dialogues Bureau10 May 2019 9:00 AM IST
    The treatment Trastuzumab Deruxtecan, or DS-8201, demonstrated a clinically meaningful response in patients with refractory HER2-positive metastatic...
    Mylan launches Advair generic at 70 percent discount in US

    Mylan launches Advair generic at 70 percent discount in US

    Farhat Nasim14 Feb 2019 9:15 AM IST
    The treatment, the first generic of Advair, is approved in three doses and will be priced between $93.71 and $153.14, the company said.U.S: Mylan NV...
    GSK bets on pioneering cancer therapy with Adaptimmune deal

    GSK bets on pioneering cancer therapy with Adaptimmune deal

    Ruby Khatun Khatun9 Sept 2017 9:32 AM IST
    LONDON: GlaxoSmithKline (GSK) said it has licensed the rights to Adaptimmune's pioneering T-cell therapy program to boost its pipeline in oncology,...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok